Literature DB >> 16988767

Immunosuppression in patients with severe acute pancreatitis.

Takashi Ueda1, Yoshifumi Takeyama, Takeo Yasuda, Makoto Shinzeki, Hidehiro Sawa, Takahiro Nakajima, Tetsuo Ajiki, Yasuhiro Fujino, Yasuyuki Suzuki, Yoshikazu Kuroda.   

Abstract

BACKGROUND: In severe acute pancreatitis (SAP), immunologic impairment in the early phase may be linked to subsequent infectious complications. In this study, immunologic alterations in patients with SAP were analyzed, and immunologic parameters related to infectious complications were clarified.
METHODS: A total of 101 patients with SAP were analyzed retrospectively. Various immunologic parameters on admission were analyzed and compared between the infection group and noninfection group during SAP. Furthermore, chronologic change in the lymphocyte count was investigated, and its utility for predicting infection was compared with conventional scoring systems.
RESULTS: Serum immunoglobulin G (IgG), serum IgM, lymphokine-activated killer cell activity, and natural killer cell activity were low, and the incidence of abnormally low values was 50.0%, 65.0%, 45.5%, and 42.4%, respectively. Serum complement factor 3 was significantly negatively correlated with the APACHE II score. The lymphocyte count was decreased below the normal range, and was significantly negatively correlated with the APACHE II score. CD4-, CD8-, and CD20-positive lymphocyte counts were below the normal range, and CD4- and CD8-positive lymphocyte counts were significantly lower in the infection group. The lymphocyte count on day 14 after admission was significantly lower in the infection group and was more useful for predicting infection than conventional scoring systems.
CONCLUSIONS: Immunosuppression occurs from the early phase in SAP, and quantitative impairment of lymphocytes, mainly T lymphocytes, may be closely related to infectious complications during SAP. CD4- and CD8-positive lymphocyte counts on admission and the lymphocyte count on day 14 after admission may be useful for predicting infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16988767     DOI: 10.1007/s00535-006-1852-8

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  30 in total

1.  Development and use of a new staging system for severe acute pancreatitis based on a nationwide survey in Japan.

Authors:  Michio Ogawa; Masahiko Hirota; Tetsuo Hayakawa; Seiki Matsuno; Shinichiro Watanabe; Yutaka Atomi; Makoto Otsuki; Kei Kashima; Masaru Koizumi; Hideo Harada; Masahiro Yamamoto; Isao Nishimori
Journal:  Pancreas       Date:  2002-11       Impact factor: 3.327

2.  Evaluation of severity of acute pancreatitis. According to a report of the cooperative national survey in Japan.

Authors:  Y Saitoh; M Yamamoto
Journal:  Int J Pancreatol       Date:  1991

3.  Peripheral lymphocyte reduction in severe acute pancreatitis is caused by apoptotic cell death.

Authors:  Y Takeyama; K Takas; T Ueda; Y Hori; M Goshima; Y Kuroda
Journal:  J Gastrointest Surg       Date:  2000 Jul-Aug       Impact factor: 3.452

4.  Thymic atrophy caused by thymocyte apoptosis in experimental severe acute pancreatitis.

Authors:  Y Takeyama; J Nishikawa; T Ueda; Y Hori
Journal:  J Surg Res       Date:  1998-08       Impact factor: 2.192

5.  Impaired lymphocyte proliferation in human acute pancreatitis.

Authors:  R Pezzilli; P Billi; E Beltrandi; M Casadei Maldini; R Mancini
Journal:  Digestion       Date:  1997       Impact factor: 3.216

6.  Bacterial infection and extent of necrosis are determinants of organ failure in patients with acute necrotizing pancreatitis.

Authors:  R Isenmann; B Rau; H G Beger
Journal:  Br J Surg       Date:  1999-08       Impact factor: 6.939

7.  Splenic atrophy in experimental severe acute pancreatitis.

Authors:  Takeo Yasuda; Yoshifumi Takeyama; Takashi Ueda; Kozo Takase; Junsuke Nishikawa; Yoshikazu Kuroda
Journal:  Pancreas       Date:  2002-05       Impact factor: 3.327

8.  Surgical strategy and management of infected pancreatic necrosis.

Authors:  G Farkas; J Márton; Y Mándi; E Szederkényi
Journal:  Br J Surg       Date:  1996-07       Impact factor: 6.939

9.  The serum complement system--a mediator of acute pancreatitis.

Authors:  R Seelig; V Ehemann; C Tschahargane; H P Seelig
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1975

10.  Immune function in patients with acute pancreatitis.

Authors:  Soichiro Uehara; Katsuhiro Gothoh; Hiroshi Handa; Hiroshi Tomita; Yoshimura Tomita
Journal:  J Gastroenterol Hepatol       Date:  2003-04       Impact factor: 4.029

View more
  17 in total

1.  Thymosin alpha 1 is associated with improved cellular immunity and reduced infection rate in severe acute pancreatitis patients in a double-blind randomized control study.

Authors:  Xinying Wang; Weiqin Li; Chenglin Niu; Liya Pan; Ning Li; Jieshou Li
Journal:  Inflammation       Date:  2011-06       Impact factor: 4.092

Review 2.  Advances in researches on the immune dysregulation and therapy of severe acute pancreatitis.

Authors:  Xi-Ping Zhang; Han-Qing Chen; Fang Liu; Jie Zhang
Journal:  J Zhejiang Univ Sci B       Date:  2009-07       Impact factor: 3.066

Review 3.  Immunomodulatory therapies for acute pancreatitis.

Authors:  Jing Li; Wen-Juan Yang; Lu-Ming Huang; Cheng-Wei Tang
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

4.  Different profiles of cytokine expression during mild and severe acute pancreatitis.

Authors:  Zilvinas Dambrauskas; Nathalia Giese; Antanas Gulbinas; Thomas Giese; Pascal O Berberat; Juozas Pundzius; Giedrius Barauskas; Helmut Friess
Journal:  World J Gastroenterol       Date:  2010-04-21       Impact factor: 5.742

5.  Immune dysregulation in patients with severe acute pancreatitis.

Authors:  YinFeng Shen; NaiQiang Cui; Bing Miao; ErPeng Zhao
Journal:  Inflammation       Date:  2011-02       Impact factor: 4.092

6.  Immune enhancement in patients with predicted severe acute necrotising pancreatitis: a multicentre double-blind randomised controlled trial.

Authors:  Lu Ke; Jing Zhou; Wenjian Mao; Tao Chen; Yin Zhu; Xinting Pan; Hong Mei; Vikesh Singh; James Buxbaum; Gordon Doig; Chengjian He; Weili Gu; Weihua Lu; Shumin Tu; Haibin Ni; Guoxiu Zhang; Xiangyang Zhao; Junli Sun; Weiwei Chen; Jingchun Song; Min Shao; Jianfeng Tu; Liang Xia; Wenhua He; Qingyun Zhu; Kang Li; Hongyi Yao; Jingyi Wu; Long Fu; Wendi Jiang; He Zhang; Jiajia Lin; Baiqiang Li; Zhihui Tong; John Windsor; Yuxiu Liu; Weiqin Li
Journal:  Intensive Care Med       Date:  2022-06-17       Impact factor: 41.787

Review 7.  Complex role for the immune system in initiation and progression of pancreatic cancer.

Authors:  Kristin S Inman; Amanda A Francis; Nicole R Murray
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

8.  The role of Fas expression on the occurrence of immunosuppression in severe acute pancreatitis.

Authors:  Yueqiu Qin; Liao Pinhu; Yanwu You; Suren Sooranna; Zhansong Huang; Xihan Zhou; Yixia Yin; Sien Song
Journal:  Dig Dis Sci       Date:  2013-07-17       Impact factor: 3.199

Review 9.  Acute pancreatitis in HIV/AIDS patients: an issue of concern.

Authors:  Gordana Dragovic
Journal:  Asian Pac J Trop Biomed       Date:  2013-06

10.  Overexpression of Fas and FasL is associated with infectious complications and severity of experimental severe acute pancreatitis by promoting apoptosis of lymphocytes.

Authors:  Liao Pinhu; Yueqiu Qin; Bin Xiong; Yanwu You; Jun Li; Suren R Sooranna
Journal:  Inflammation       Date:  2014-08       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.